Immature Platelet Fraction as a Promising Biomarker in Prediction Outcome of HELLP Syndrome
Learn more about:
Related Clinical Trial
PlacEntal Acute Atherosis RefLecting Subclinical Atherosclerosis
Pregnancy-Related Hypertension: Adherence to a New Type of Monitoring
A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy
RCT of Antioxidant Therapy to Prevent Preeclampsia in Brazil
Pancreatic Stone Protein (PSP) in Pregnant Women
Early Vascular Adjustments to Prevent Preeclampsia
Women Specific Cardiac Recovery After Preeclampsia
Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features
Calcium for Pre-Eclampsia Prevention (CPEP)
Influence of Conditional Workout Postpartum on Arterial Stiffness Among Women With Status After Preeclampsia, Superimposed Preeclampsia or HELLP-syndrome
Correlation of Survival in Puerperae by Electrical Impedance Tomography
Immature Platelet Fraction as a Promising Biomarker in Prediction Outcome of HELLP Syndrome
Dexamethasone Efficacy in HELLP I Syndrome
The Preeclampsia Registry
Effectivity of Postpartum Dexamethasone for Women With Class I HELLP Syndrome
General Anesthesia Versus Spinal Anesthesia in Patients of HELLP Syndrome